Memantine for Enhanced Stroke Recovery


Phase Early 1 Results N/A

Summary of Purpose

This will be a randomized double blind placebo-controlled pilot study using a repeated measures design in which participants with acute ischemic stroke and upper extremity weakness are randomized to either drug or placebo

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 6 August 2017.

1 Jan 2014 27 Jan 2014 1 Nov 2018 1 Dec 2018 1 Aug 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


  • Alicia Bennett, D.O.

  • Jennifer Majersik, M.D.